For Investors

Press Releases

ReWalk Robotics to Present at the H.C. WAINWRIGHT 6th Annual Israel Virtual Conference on November 12th, 2020

11/09/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Nov. 09, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer, Ori Gon Chief Financial Officer and Andy Dolan , VP Marketing and Reimbursement

ReWalk Robotics to Report Third Quarter 2020 Financial Results on November 10, 2020

11/06/20

MARLBOROUGH, Mass.   BERLIN, Germany and YOKNEAM ILIT, Israel , Nov. 06, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its third quarter 2020 financial results on Tuesday, November 10, 2020 , before the U.S.

ReWalk Robotics Receives Medicare Provider Certification

10/20/20

Centers for Medicare & Medicaid Authorization Enables ReWalk to Bill Medicare Directly MARLBOROUGH, Mass. , Oct. 20, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd.  (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today

ReWalk Robotics announces the Appointment of Randel E. Richner, BSN, MPH to its Board of Directors

10/19/20

Ms. Richner is an experienced public health policy professional with over 30 years of experience in Medical Devices, Reimbursement Strategy and Health Care Policy MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel and BERLIN , Oct. 19, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics. Ltd.

ReWalk Robotics to Present at the H.C. WAINWRIGHT 22nd Annual Global Investment Virtual Conference on September 15th, 2020

09/10/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Sept. 10, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer, Ori Gon , Chief Financial Officer and Andy Dolan , VP Marketing and

U.S. Court of Appeals Dismisses Securities Lawsuit Against ReWalk Robotics

08/27/20

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 27, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced that the U.S.

ReWalk Robotics Reports Second Quarter 2020 Financial Results

08/12/20

MARLBOROUGH, Mass. and BERLIN, Germany and YOKNEAM ILIT, Israel , Aug. 12, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced its financial results for the three and six months ended June 30, 2020 .

ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020

08/07/20

MARLBOROUGH, Mass.   BERLIN, Germany and YOKNEAM ILIT, Israel , Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020 , before the U.S.

Centers for Medicare & Medicaid Services Issues Code for ReWalk Personal Exoskeleton

07/15/20

First of Its Kind HCPCS Level II Code is a Breakthrough for Access to Exoskeletons for Individuals with Spinal Cord Injury   Company Will Seek Coverage Policies with U.S. National, State and Private Payors MARLBOROUGH, Mass. , July 15, 2020 /PRNewswire/ -- ReWalk Robotics, Ltd.

ReWalk Robotics Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/06/20

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , July 06, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced registered direct offering of approximately 4,938,278 of the Company’s ordinary shares, at a

ReWalk Robotics Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

07/01/20

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel , July 01, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with several institutional investors providing for the issuance of approximately 4,938,278

ReWalk Announces Publication of ReStore Powered Exo-Suit Clinical Study Results

06/22/20

Primary Study End Points of Device Safety and Feasibility Received Positive Results; Majority of Participants Experienced Clinically Meaningful Walking Speed Improvements MARLBOROUGH, Mass. , June 22, 2020 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a